rough rearview mirror
posit risk/reward follow sell-off stock take time
remain op-rat given favor risk/reward follow declin
stock vs flat declin driven reduct
guidanc mid-point adjust restructur top multipl
contract stock reaction today would differ
product outsid busi transform linger environment
concern pfa take time resolv necessarili
view catalyst noisi howev think stock
start outperform execut new restructur program
investor becom confid acceler
debat macro
trend mix
stress test bridg rang base
known headwind tailwind compar reduc
ep estim assum histor valuat rang
premium hold see mid-single-digit downsid compar mid-
teen upsid posit skew howev take patienc
report adjust ep
estimate/consensu china automot electron
drove declin organ revenu adj oper margin declin
driven product challeng organ volum
product challeng signific industrial-
relat busi within apac price/raw materi inflat
manag expect anoth organ revenu declin
valuation/ risk lower tp base
ep estim tp
base premium equat cs
ebitda vs current consensu risk includ slowdown global
gdp/ip price/infl broaden pfa litig
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
price apr rate outperform target price analyst john walsh
profit tax
chang work capit
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
 close
valuat base sale compound-annual-growth-rate
increment margin also
assum increas leverag use addit
capit buy back stock appli blue sky ep
estim get blue sky valu
grey valuat base sale compound-annual-growth-rate
increment margin appli
grey sky ep estim get
grey sky valu
manufactur market rang product
servic global presenc follow busi
industri safeti graphic health electron
consum
charl martineau univers toronto ep bridg valuat tabl
see ep forecast rang favor risk/reward
figur bridg valuat tabl
share repurchas net interest
charg expect
total save
gross share repurchas
organ growth increment leverag
dilut first month neutral ex ppa one-tim
valuat tabl bridg
histor trade
histor trade
valuat tabl cs ep
histor trade
expect model organ sale growth line
call said would surpris see neg growth flat ep
larg driven restructur save run rate
achiev
revis lower adjust ep guidanc
includ net hit restructur action restructur
charg restructur benefit organ growth expect
lower margin estim
vs previous manag lower capital-expenditure
guidanc convers share repurchas
reduct midpoint
segment realign began oper four new segment five
april discuss note new segment align
manag chang think realign make sens especi go-
to-market perspect align oe distribut model figur detail
introduc organ growth guidanc new segment manag
optimist outlook health consum safeti
industri expect transport electron expect
flat
adhes tape
closur mask system
separ purif
stationeri offic
corpor unalloc
elimin dual credit
adhes tape
closur mask system
separ purif
stationeri offic
within consum remaind safeti
margin exclud pfa charg adjust gross margin declin
organ volum declin product issu factori result
oper margin declin modal acquisit close februari
primari contributor margin declin acquisitions/divestitur
partial off-set price excess inflat fx net hedg impact
margin guid vs initi expect
restructur action announc new restructur action
expect gener save balanc
restructur primarili reduc headcount posit
expect elimin emphasi under-perform busi
compani anticip pre-tax charg
litig charg litig reserv result pre-tax charg per
share relat two differ issu first establish reserv
environment matter litig relat histor manufactur dispos
pfas-contain wast reserv includ product claim relat
pfa second compani increas respir reserv address
current expect futur coal mine dust lawsuit kentucki west virginia
 organ growth decreas declin industri safeti graphic
health partial off-set lsd growth consum price
volum declin
asia pacif organ sale declin driven weak china automot
electron china/hk declin japan declin ex-electron japan
industri consum declin health bright spot
hsd organ basi
emea organ revenu increas manag see benefit
erp deploy fx headwind growth quarter
latam canada sale grew organ led brazil volum declin
slightli price increas fx headwind growth
charl martineau univers toronto figur organ volum chang region
figur organ price chang region
industri broad-bas slowdown across industri sub-busi led
organ sale declin y/i automot oem y/i partial due
channel inventori reduct china overal global car/light truck market
advanc materi busi post posit growth
quarter oper margin declin back sale declin
adhes tape
closur mask system
separ purif
safeti graphic organ revenu essenti flat driven
safeti organ commerci solut roof granul transport
safeti declin weakest region organ basi
op margin declin due gain divestitur
drug deliveri hit segment organ growth apac grew quarter
posit organ growth food safeti hsd health inform system
msd medic solut lsd oral lsd modal acquisit
neg impact oper margin quarter
electron grew electron declin lead
overal organ sale declin apac declin manag attribut
electron weak soft consum electron factori autom
revenu growth consum segment organ growth led
filtret command brand apac declin driven lower demand
stationeri offic
charl martineau univers toronto compani mention price
